← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2022Last known activity
Nov 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 3 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (3)
- NCT06376162Lead sponsorPhase 1Nov 30, 2024
- NCT05320380Lead sponsorPhase 1/Phase 2Dec 20, 2022
- NCT05183035Lead sponsorPhase 3Oct 1, 2022
Details
- Last known activity
- Nov 30, 2024